We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Audentes Therapeutics, Inc in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 186 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 188 → 0 (-188)

100% less funds holding in top 10

Funds holding in top 10: 19 → 0 (-19)

100% less capital invested

Capital invested by funds: $2.57B → $0 (-$2.57B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 186

Holders
–
Holders Change
-188
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
186
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
BlackRock
BlackRock
New York
-$220M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$193M
3
MF
Magnetar Financial
Illinois
-$95.4M
4
AAM
Alpine Associates Management
Florida
-$87.1M
5
AA
AQR Arbitrage
Connecticut
-$81.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
– -$220M -3,678,864 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$193M -3,225,613 Closed
MF
3
Magnetar Financial
Illinois
– -$95.4M -1,594,605 Closed
AAM
4
Alpine Associates Management
Florida
– -$87.1M -1,456,000 Closed
AA
5
AQR Arbitrage
Connecticut
– -$81.3M -1,358,308 Closed
State Street
6
State Street
Massachusetts
– -$78.3M -1,309,250 Closed
PHS
7
PFM Health Sciences
California
– -$73.8M -1,232,873 Closed
FCM
8
Farallon Capital Management
California
– -$71.2M -1,190,000 Closed
RCM
9
RA Capital Management
Massachusetts
– -$54M -902,383 Closed
CC
10
Casdin Capital
New York
– -$51.5M -860,000 Closed
Bank of America
11
Bank of America
North Carolina
– -$50.1M -836,641 Closed
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
– -$49.3M -823,251 Closed
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
– -$48.3M -806,830 Closed
BBA
14
Baker Bros. Advisors
New York
– -$48.2M -804,720 Closed
Goldman Sachs
15
Goldman Sachs
New York
– -$47.3M -790,053 Closed
SCS
16
Syquant Capital SAS
France
– -$45.9M -767,502 Closed
UBS Group
17
UBS Group
Switzerland
– -$45M -752,003 Closed
GF
18
Gabelli Funds
New York
– -$44.4M -742,692 Closed
VI
19
Versor Investments
New York
– -$43.7M -729,714 Closed
GLAM
20
Gardner Lewis Asset Management
Pennsylvania
– -$38.7M -647,460 Closed
RG
21
Redmile Group
California
– -$38.2M -639,095 Closed
Geode Capital Management
22
Geode Capital Management
Massachusetts
– -$37.9M -633,253 Closed
Wellington Management Group
23
Wellington Management Group
Massachusetts
– -$37.2M -622,011 Closed
WIC
24
Water Island Capital
New York
– -$34.4M -574,815 Closed
BCM
25
Beryl Capital Management
California
– -$32.9M -550,426 Closed
1
2 3 4 5

BOLD Hedge Fund Activity: Q1 2020 in Review

0 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q1 2020, worth a combined $0 — down 100% from $2.57B a quarter earlier.

Sellers outnumbered buyers: 186 funds closed out of BOLD and 0 opened new positions — a net loss of 186 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $220M sold.

  • 0 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q1 2020, down from 188 in Q4 2019.
  • Funds reported $0 of Audentes Therapeutics, Inc stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Audentes Therapeutics, Inc positions in Q1 2020 and 186 closed out, a net change of -186 holders.
  • The largest Audentes Therapeutics, Inc seller in Q1 2020 was BlackRock, an estimated $220M sold.

Based on aggregated 13F filings for Q1 2020.